1369430-93-2

Basic information

• Product Name: C₅₂H₇₃N₃O₁₅
• Synonyms: C₅₂H₇₃N₃O₁₅
• CAS NO: 1369430-93-2
• Molecular Weight: 980.163
• Mol File: 1369430-93-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₅₂H₇₃N₃O₁₅(CAS DataBase Reference)
• NIST Chemistry Reference: C₅₂H₇₃N₃O₁₅(1369430-93-2)
• EPA Substance Registry System: C₅₂H₇₃N₃O₁₅(1369430-93-2)

Safety Data

• Hazardous Substances Data: 1369430-93-2(Hazardous Substances Data)

Upstream product

• 32469-28-6 (3R,4S,5R,6R)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one 
• 16606-30-7 2,4-dibromo-5-isopropylphenol 
• 24078-12-4 4-bromo-2-methylbenzaldehyde 
• 1240304-51-1 C₃₃H₃₉BrO₁₂ 
• 1240304-46-4 (1S)-1,5-anhydro-1-{5-bromo-4-(propan-2-yl)-2-[(trimethylsilyl)oxy]phenyl}-2,3,4,6-tetrakis-O-(trimethylsilyl)-D-glucitol 
• 1240304-31-7 (1S)-2,3,4,6-tetra-O-acetyl-1-[2-(acetyloxy)-5-[(4-bromo-2-methylphenyl)methyl]-4-(propan-2-yl)phenyl]-1,5-anhydro-D-glucitol 
• 1240304-37-3 (1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[2-(benzyloxy)-4-(propan-2-yl)phenyl]-D-glucitol 
• 1240304-48-6 C₂₃H₂₉BrO₇ 
• 1240304-44-2 (1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[5-bromo-2-hydroxy-4-(propan-2-yl)phenyl]-D-glucitol 
• 1240304-42-0 (1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[2-hydroxy-4-(propan-2-yl)phenyl]-D-glucitol 
• 1359948-56-3 C₄₀H₇₃BrO₉Si₅ 
• 1359948-58-5 C₃₆H₄₃BrO₁₄ 
• 1359948-57-4 C₂₄H₃₁BrO₈ 
• 1240304-83-9 C₂₁H₃₃N₃O₅ 

Downstream Products

• 1369430-91-0 C₄₇H₆₅N₃O₁₃ 

Relevant articles and documents

4 -ISOPROPYLPHENYL GLUCITOL COMPOUNDS AS SGLTL INHIBITORS

The present invention provides 4-isopropylphenyl glucitol compounds which have no tendency to accumulate in the body and which inhibit SGLT1 activity to suppress postprandial hyperglycemia (or impaired glucose tolerance) through suppression of glucose absorption in the small intestine, whereby the compounds, for example, can suppress the onset of diabetes and metabolic syndrome or can treat these diseases. A 4-isopropylphenyl glucitol compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: [Chem. 1] wherein R1 represents a hydrogen atom, etc., R2 represents a methyl group, etc., R3 represents a C1-4 alkyl group substituted with an amino group(s), etc., and R4 represents a hydrogen atom, etc.